Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/181726
Title: | OLB-AC: toward optimizing ligand bioactivities through deep graph learning and activity cliffs | Authors: | Yin, Yueming Hu, Haifeng Yang, Jitao Ye, Chun Goh, Wilson Wen Bin Kong, Adams Wai Kin Wu, Jiansheng |
Keywords: | Computer and Information Science | Issue Date: | 2024 | Source: | Yin, Y., Hu, H., Yang, J., Ye, C., Goh, W. W. B., Kong, A. W. K. & Wu, J. (2024). OLB-AC: toward optimizing ligand bioactivities through deep graph learning and activity cliffs. Bioinformatics, 40(6), e365-. https://dx.doi.org/10.1093/bioinformatics/btae365 | Journal: | Bioinformatics | Abstract: | Motivation: Deep graph learning (DGL) has been widely employed in the realm of ligand-based virtual screening. Within this field, a key hurdle is the existence of activity cliffs (ACs), where minor chemical alterations can lead to significant changes in bioactivity. In response, several DGL models have been developed to enhance ligand bioactivity prediction in the presence of ACs. Yet, there remains a largely unexplored opportunity within ACs for optimizing ligand bioactivity, making it an area ripe for further investigation. Results: We present a novel approach to simultaneously predict and optimize ligand bioactivities through DGL and ACs (OLB-AC). OLB-AC possesses the capability to optimize ligand molecules located near ACs, providing a direct reference for optimizing ligand bioactivities with the matching of original ligands. To accomplish this, a novel attentive graph reconstruction neural network and ligand optimization scheme are proposed. Attentive graph reconstruction neural network reconstructs original ligands and optimizes them through adversarial representations derived from their bioactivity prediction process. Experimental results on nine drug targets reveal that out of the 667 molecules generated through OLB-AC optimization on datasets comprising 974 low-activity, noninhibitor, or highly toxic ligands, 49 are recognized as known highly active, inhibitor, or nontoxic ligands beyond the datasets’ scope. The 27 out of 49 matched molecular pairs generated by OLB-AC reveal novel transformations not present in their training sets. The adversarial representations employed for ligand optimization originate from the gradients of bioactivity predictions. Therefore, we also assess OLB-AC’s prediction accuracy across 33 different bioactivity datasets. Results show that OLB-AC achieves the best Pearson correlation coefficient (r2) on 27/33 datasets, with an average improvement of 7.2%–22.9% against the state-of-the-art bioactivity prediction methods. Availability and implementation: The code and dataset developed in this work are available at github.com/Yueming-Yin/OLB-AC. | URI: | https://hdl.handle.net/10356/181726 | ISSN: | 1367-4803 | DOI: | 10.1093/bioinformatics/btae365 | Schools: | College of Computing and Data Science Lee Kong Chian School of Medicine (LKCMedicine) School of Biological Sciences |
Research Centres: | Center for Biomedical Informatics Center for AI in Medicine |
Rights: | © 2024 The Author(s). Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | Fulltext Permission: | open | Fulltext Availability: | With Fulltext |
Appears in Collections: | CCDS Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
btae365.pdf | 4.18 MB | Adobe PDF | View/Open |
Page view(s)
63
Updated on Mar 28, 2025
Download(s)
3
Updated on Mar 28, 2025
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.